ESC Premium Access

Clinical effectiveness of new oral anticoagulants in US and Europe for stroke prevention in atrial fibrillation

Congress Presentation

About the speaker

Mr Marc Tarsillo

Quinnipiac University , North Haven (United States of America)
0 follower

4 more presentations in this session

Anti-Xa concentration better than activated partial thromboplastin time for the monitoring of unfractionated heparin treatment.

Speaker: Doctor T. Moumneh (Angers, FR)


Effects of factor Xa inhibitors rivaroxaban and apixaban on platelet function

Speaker: Associate Professor G. Renda (Chieti, IT)


Impact of hemorrhagic events during dual antiplatelet therapy after drug-eluting stent implantation in patients with hemodialysis

Speaker: Doctor A. Shimizu (Kitakyushu, JP)


Use of vitamin K antagonists in patients aged 85 years or over: analysis of thromboembolic and hemorrhagic events.

Speaker: Doctor D. Moreira (Sao Paulo, BR)


Access the full session

Poster session 2 - Digging deeper into oral anticoagulants

Speakers: Mr M. Tarsillo, Doctor T. Moumneh, Associate Professor G. Renda, Doctor A. Shimizu, Doctor D. Moreira

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb